The 2023-24 Federal Budget was delivered on 9 May 2023. MS Australia’s analysis of this Budget is through the lens of the two areas of fundamental need for people living with MS.
People with MS are helping us build the evidence for better government MS support.
CEO Rohan Greenland talks about the world’s first multi-arm, multi-stage trial for progressive MS named ‘OCTOPUS’, which recently launched in the UK and the hope that in time Australia will be able to link up with this globally significant ‘mega trial’ with our own trial sites.
A new randomised controlled trial has found that people with neurological conditions (including MS) who receive a purposely designed internet-delivered psychological program, including cognitive behaviour therapy (CBT), report improvements in their depression, anxiety and functional disability levels.
Australian researchers have investigated the use of a sensitive measure of walking stability in people with MS at the early stages of disease.
Dr Ken Doyle has always been interested in cutting-edge research – but when it comes to MS, his interest is personal. Ken wants to fast-track a cure by ensuring MS research is appropriately funded.
MS Australia President, Associate Professor Des Graham, writes with multiple sclerosis increasing at a significant and accelerating rate, awareness and understanding of the often invisible disease is more important than ever.
The ‘What is MS?’ video attempts to demystify and explain a complex, and often at times, invisible disease that now impacts more than 33,000 Australians.
Australian researchers have investigated whether genetics and epigenetics contribute to the severity of MS.
